<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>API Manufacturers</title>
    <link>https://www.taxtmi.com/news?id=25052</link>
    <description>The document describes three government schemes to bolster domestic production of APIs, KSMs and DIs: a PLI sub scheme that grants sales linked incentives for 41 identified products across target segments; a PLI Scheme for Pharmaceuticals including APIs under operational guidelines to encourage broader pharmaceutical manufacturing; and a Bulk Drug Parks scheme to establish up to three parks providing Common Infrastructure Facilities to support clustered API production.</description>
    <language>en-us</language>
    <pubDate>Thu, 03 Feb 2022 09:54:18 +0530</pubDate>
    <lastBuildDate>Thu, 03 Feb 2022 09:55:00 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=669245" rel="self" type="application/rss+xml"/>
    <item>
      <title>API Manufacturers</title>
      <link>https://www.taxtmi.com/news?id=25052</link>
      <description>The document describes three government schemes to bolster domestic production of APIs, KSMs and DIs: a PLI sub scheme that grants sales linked incentives for 41 identified products across target segments; a PLI Scheme for Pharmaceuticals including APIs under operational guidelines to encourage broader pharmaceutical manufacturing; and a Bulk Drug Parks scheme to establish up to three parks providing Common Infrastructure Facilities to support clustered API production.</description>
      <category>News</category>
      <law>-</law>
      <pubDate>Thu, 03 Feb 2022 09:54:18 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/news?id=25052</guid>
    </item>
  </channel>
</rss>